| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.27 | 1e-05 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.25 | 3e-05 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.03 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |